1 | Page This is an Accepted Manuscript of an article published in [Qual Health Res], available online at http://qhr.sagepub.com/content/25/3/408.short (paywalled) Self-archived in the Sydney eScholarship Repository by the Centre for Values, Ethics and the Law in Medicine (VELiM), University of Sydney, Australia Please cite as: Halliday LE, Boughton MA, Kerridge I. Liminal Reproductive Experiences after Therapies for Hematological Malignancy. Qual Health Res. March 2015 vol. 25 no. 3 408-416. Liminal Reproductive Experiences After Therapies for Hematological Malignancy Halliday LE, Boughton MA, Kerridge I. (2015) Abstract In this article, we discuss the psychosocial health of young women related to fertility, pregnancy, and motherhood after therapies for hematological malignancies. We utilized a hermeneutical phenomenological approach to conduct in-depth interviews with 12 women who had previously received treatment for a hematological malignancy and had experienced uncertainty surrounding their ability to start or extend their biological family. Our presented findings are interpretations of the women’s own words as they articulated how they inhabited a liminal space. We concluded that although fertility and motherhood possibly might not be immediate concerns when they received a diagnosis of hematological malignancy, young women could subsequently experience ongoing issues and concerns related to reproductive uncertainty and motherhood capabilities, which have the potential to affect emotionally and psychosocially on their lives. These issues might possibly require longer-term support, counseling, and informational resources. We also discuss the strengths, limitations, and implications of the study. Keywords: cancer, psychosocial aspects; coping and adaptation; fertility / infertility; hermeneutics; lived experience; mothers, mothering; phenomenology; pregnancy; reproduction Advances in cancer detection and treatment have significantly improved the outlook for people who receive a diagnosis; however, treatment and management of the disease is not enough to ensure good longer-term quality of life (Redig, Brannigan, & Stryker, 2011; Schover, 2009). Complications of the disease and its related treatments are therefore becoming health issues that will continue to increase in importance as the number of survivors increases (Saxman, 2005). One complication that is now recognized is fertility impairment, which has a substantial adverse influence on various medical and quality of life domains of survivorship (Meneses, McNees, & Azuero, 2010; Redig et al., 2011; Stern & Seymour, 2006).